Trends and inequities in beta-blocker prescribing for heart failure

Author： Shah Sunil M   Carey Iain M   DeWilde Stephen   Richards Nicky   Cook Derek G  

Publisher： Royal College of General Practitioners

ISSN： 1478-5242

Source： British Journal of General Practice, Vol.58, Iss.557, 2008-12, pp. : 862-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 64-67

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Statin Therapy on Clinical Outcomes in Chronic Heart Failure Patients According to Beta-Blocker Use: Results of CIBIS II

By  

Cardiology, Vol. 108, Iss. 1, 2006-09 ,pp. : 28-34

Karger

Access to resources Recommend Favorite

Beta‐blocker therapy and prognosis of heart failure patients with new‐onset diabetes mellitus

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 550-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pediatric prescriptions for HF medicine

By  

CONGENITAL HEART DISEASE, Vol. 10, Iss. 1, 2015-01 ,pp. : 78-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time-of-day variation in cardiovascular response to maximal exercise testing in coronary heart disease patients taking a beta-blocker

By Dufour Doiron Monique   Prud’homme Denis   Boulay Pierre  

Applied Physiology, Nutrition, and Metabolism, Vol. 32, Iss. 4, 2007-08 ,pp. : 664-669

NRC Research Press

Access to resources Recommend Favorite